Skip to main content

Day: September 12, 2022

Novo Nordisk and Microsoft collaborate to accelerate drug discovery and development using big data and artificial intelligence

Bagsværd, Denmark and Redmond, WA, US, 12 September 2022 – Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence (AI) with Novo Nordisk’s drug discovery, development and data science capabilities. Through the partnership, Microsoft is providing AI technology, foundational science models and expertise and is working alongside Novo Nordisk’s data scientists and domain experts from early research and development areas to accelerate Novo Nordisk’s R&D. “We are very excited about this new partnership that allows us to work closely together with key experts from Microsoft as we look to expand our digital science and AI capabilities,” said Lars Fogh Iversen, senior vice president, Digital Science & Innovation at Novo Nordisk. “Together,...

Continue reading

Endeavour Silver Completes the Sale of the El Compas Property to Grupo ROSGO for US$5.0 million

VANCOUVER, British Columbia, Sept. 12, 2022 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) is pleased to announce it has entered into an agreement to sell a 100% interest in Minera Oro Silver de Mexico, S.A. de C.V. (“MOS”), a wholly owned subsidiary of Endeavour to Grupo ROSGO, S.A. de C.V., (“Grupo ROSGO”). MOS holds the El Compas property and the lease on the La Plata processing plant in Zacatecas, Mexico. All references to dollars ($) in this news release are to United States dollars. Pursuant to the agreement, Grupo ROSGO will pay Endeavour $5 million cash over five years with an initial payment of $250,000 on signing of the definitive agreement. Instalment payments of $500,000 will be made every six months other than the third payment, which will be $750,000. The payments are...

Continue reading

Pharvaris Reports Second Quarter 2022 Financial Results and Provides Business Update

Formal letters received from FDA relating to the previously announced hold on clinical studies of PHA121 in the U.S. Top-line data anticipated in 4Q22 for RAPIDe-1, a global Phase 2 study of PHVS416 for the acute treatment of HAE attacks ongoing outside the U.S. Executing from a strong financial position with cash and cash equivalents of €201 million as of June 30, 2022ZUG, Switzerland, Sept. 12, 2022 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today reported financial results for the second quarter ended June 30, 2022, and provided a business update. “Pharvaris is dedicated to bringing therapeutic alternatives to people living with HAE and we maintain our belief in the potential of PHA121....

Continue reading

Hersha Hospitality Trust to Sell Hotel Milo Santa Barbara and Pan Pacific Seattle for $125 Million

– Net Proceeds are expected to be used for general corporate purposes including, but not limited to, additional debt repayment and dividend payments – – Price implies a blended 2.9% cap rate and 27.0x EBITDA multiple on 2019 results and a $455K per key valuation – PHILADELPHIA, Sept. 12, 2022 (GLOBE NEWSWIRE) — Hersha Hospitality Trust (NYSE: HT) (“Hersha” or the “Company”), owner of luxury and lifestyle hotels in coastal gateway and resort markets, today announced that it has entered into definitive agreements to sell two of its West Coast properties for gross proceeds of $125 million, or approximately $455,000 per key. Mr. Jay H. Shah, Hersha’s Chief Executive Officer, stated, “We’re pleased to have reached two separate agreements that are expected to increase our operational flexibility while furthering our long-term strategic...

Continue reading

Virbac : Declaration of the number of shares and voting rights 08/2022

              DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS       Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)         Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577  Date Total number of shares representing the share capital Total number of voting rightsAugust, 31 2022 8 458 000 Gross total of voting rights : 12 766 133Net total* of voting rights : 12 760 706  Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.               VIRBAC: Shaping the future of animal health NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP Corporate Finance:...

Continue reading

Virbac : Declaration of the number of shares and voting rights 07/2022

              DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS       Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)         Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577  Date Total number of shares representing the share capital Total number of voting rightsJuly, 31 2022 8 458 000 Gross total of voting rights : 12 766 223Net total* of voting rights : 12 759 201  Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.               VIRBAC: Shaping the future of animal health NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP Corporate Finance:...

Continue reading

Sydbank share buyback programme: transactions in week 36

        Company Announcement No 43/2022Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk12 September 2022  Dear Sirs Sydbank share buyback programme: transactions in week 36On 2 March 2022 Sydbank announced a share buyback programme of DKK 425m. The share buyback commenced on 7 March 2022 and will be completed by 30 December 2022. The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under the share buyback...

Continue reading

ZeroFox Exhibits at FS-ISAC Europe, Sharing Solutions and Best Practices for Addressing Growing External Cybersecurity Threats

–  On Sept. 13, ZeroFox’s Brian Kime will lead a conversation titled “Planning is Indispensable: Tools to Ensure TI Success” –  ZeroFox will exhibit at booth #24 MADRID, Spain, Sept. 12, 2022 (GLOBE NEWSWIRE) — ZeroFox, a leading external cybersecurity provider, will attend FS-ISAC Europe September 13-15, demonstrating recent product innovations in threat intelligence, digital risk protection, and breach response at booth #24. Conference attendees can join ZeroFox’s Vice President of Intelligence Strategy and Advisory, Brian Kime, tomorrow, September 13th at 3:15 pm local time, for a presentation on essential planning tools for threat intelligence programs. The financial services industry remains both a top target for cybercrime and a top customer cohort for ZeroFox. ZeroFox continues to observe security incidents...

Continue reading

Caroline Sasia joins Soitec’s Executive Committee as Senior Vice President, Head of Communications & Chief of Staff to the CEO

Caroline Sasia joins Soitec’s Executive Committee as Senior Vice President, Head of Communications & Chief of Staff to the CEO Bernin (Grenoble), France, September 12, 2022 – Soitec (Euronext Paris), a world leader in the design and production of innovative semiconductor materials today announced the   appointment of Caroline Sasia as Senior Vice President, Head of Communications & Chief of Staff to the CEO. In this role, she joins Soitec’s Executive Committee. The appointment of Caroline Sasia is part of Soitec’s continuous effort to strengthen its organization around three divisions which was initiated at the beginning of the year to support the company’s growth ambitions and meet the expectations of its different stakeholders. With over 20 years of professional experience, Caroline Sasia has a strong expertise...

Continue reading

Mise à disposition du rapport financier semestriel 30 Juin 2022 – Crédit Agricole Touraine Poitou

Le Crédit Agricole de la Touraine et du Poitou vous informe que son rapport financier semestriel à la date du 30 juin 2021 est consultable sur son site Internet : www.ca-tourainepoitou.fr. Ce document comprend :– le RAPPORT d’ACTIVITE sur le premier semestre 2021,– les COMPTES CONSOLIDES INTERMEDIAIRES au 30 juin 2021,– le RAPPORT des COMMISSAIRES aux COMPTES sur l’information financière semestrielle,– la DECLARATION du DIRECTEUR GENERAL. »AttachmentRapport financier 1er semestre 2022

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.